1H MRSI maps of tumor hypoxia using an extrinsic hypoxia probe by Pacheco-Torres, Jesús et al.
1H MRSI maps of tumor hypoxia using an extrinsic hypoxia probe 
Jesús Pacheco-Torres1,2, Pilar Lopez-Larrubia1, Elena Nieto3, Ramón Alajarín3, Julio Álvarez-Builla3, Paloma Ballesteros2, and 
Sebastian Cerdan1 
1Instituto de Investigaciones Biomédicas - CSIC, Madrid, Madrid, Spain, 2Universidad Nacional de Educación a Distancia 
(UNED), Madrid, Madrid, Spain, 3Universidad de Alcalá, Alcalá de Henares, Madrid, Spain 
 
Introduction: Several studies indicate a relationship between tumor hypoxia and tumor aggressiveness, poor outcome (1) and resistance to 
therapies (2). Due to the chaotic neoangiogenic development, neoplastic tissues often show hypoxic areas heterogeneously distributed in 
the tumor mass. There are several methods to measure hypoxia, but none of them have reached routine clinical application (3). 2-
Nitroimidazole derivatives (EF5, Pimonidzole, 18F-MISO) have been extensively used as molecular markers of hypoxia in combination 
with different techniques as immunohistochemistry, PET or 19F MRI (3). Here, we aimed to test whether nitroimidazole derivatives can be 
used as hypoxia marker in vivo in combination with widely applicable 1H MRSI methodologies. 
 
Materials and Methods: Nude mice (NU/NU, 20-25 g), were implanted subcutaneously with glioblastoma cells (C6) in flanks. Tumors 
were allowed to grow up to 1 cm diameter. MR evaluations were performed in vivo in a 7.0 T Bruker Pharmascan ® system using a 1H rat 
brain receive-only surface coil in combination with the actively detuned transmit-only resonator. Animals were anesthetized by inhalation 
with 2-3 % of isofluorane in an induction chamber (1 L min-1) and maintained with 2 % of isofluorane in different gases: 100 % oxygen 
(n=2) and air (n=2). MRSI was performed in two spatial dimensions, exciting a PRESS selected volume of 8 × 8 × 4 mm. Acquisition 
parameters were: FOV = 32 × 32 mm, matrix = 8 × 8 zero-filled to 32 × 32, TR = 1500 ms, TE = 19.3 ms and 500 transients acquired 
during 12.6 min. Water suppression was performed with a VAPOR sequence. After basal spectrum, the animal was removed from the 
magnet and injected intratumoraly with 50 µL of an aqueous solution of the oxygen reporter MISO (1M) and TSP (2M) using a gas tight 
syringe with a custom-made fine sharp needle. The animal was then introduced again in the magnet and the MRSI process repeated. The 
evolution of the injected reporters was monitored during at least two hours after injection. MRSI images were reconstructed and quantified 
by using 3DiCSI 1.9.9 software (Hatch Center for MR Research, Columbia University, New York, NY). The integral of MISO, TSP and 
lipids signals were measured at different times after drug administration. The percentage of TSP and hypoxia marker relative to lipid signal 
was calculated relative to the lipid signal. Only those voxels with SNR equal or bigger than 2 were taken into account. Statistical 
calculations were performed by using GraphPad Prism (GraphPad Software, Inc. La Jolla, USA). Parametric color-based maps were 
generated by using Matlab based home made software. 
Results: Fig 1 shows maps of the remaining MISO and TSP 
percentage 70 min after injection compared to that of 30 min after 
injection for hyperoxigenated (breathing 100% O2) and normoxic 
animals (breathing 21% O2). Tumors depicted statistically significant 
differences in the percentage of MISO signal remaining in animal 
breathing pure oxygen and air (P < 0.0001), whereas it was not the 
case for the percentage of TSP (P> 0.05), used as a marker for 
clearance (Fig 2). It is also important to notice that there is no spatial 
correlation for the values obtained for MISO and TSP in a voxel by 
voxel way. 
Conclusions: We showed that imaging the real time distribution of MISO and TSP is possible using 1H MRSI. Maps of the percentage of 
MISO and TSP remaining revealed high intratumor variability for both MISO (SD ≈ 10) and TSP (SD ≈ 12) in all the animals tested (Fig 1 
& 2). However, hyperoxygenated animals showed a significantly higher percentage of remaining MISO (77%) than normoxic animals 
(58%), revealing higher MISO disappearance for the lower oxygen tensions breathed. There is no such a difference in TSP, an indicator for 
neovascular clearance, which showed 72% of remaining compound for hyperoxic and normoxic tumors respectively.  The use of 1H MRSI 
to infer tumor hypoxia complements and extends earlier 1H MRSI methods implemented to measure extracellular pH (pHe) maps (4), 
allowing for the first time to our knowledge, an integral 1H MRSI approach to resolve spatially pHe and pO2 through the tumor 
microenvironment. The proposed methodology is direct and easily adaptable to clinic, especially in superficially located tumors, as lymph 
nodes from head and neck tumors, where hypoxia has been demonstrated to be particularly relevant (5). Together, present results favor the 
use of nitroimidazole derivatives as 1H MRSI hypoxia markers. 
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Fig 1. Percentage of MISO and TSP remaining in the tumor after 70 
minutes of injection relative to the initial amount detected 30 
minutes after injection. a) % of MISO in a representative  animal 
breathing pure oxygen. b) % of TSP in a representative animal 
breathing pure oxygen. c) % of MISO in representative animal 
breathing air and d) % of TSP in representative animal breathing air. 
Note the lower MISO concentration remaining in tumors from 
animals breathing lower atmospheric oxygen.  
Fig 2. MISO and TSP disappearance in vivo as detected by 1H MRSI. 
Scatter plot of the amount of MISO (left) and TSP (right) remaining in the 
tumor at 70 min relative to 30 min after the injection of the compounds in 
hyperoxygenated (blue) and normoxic (red) tumors. Note the significantly 
larger disappearance of MISO in the 21% oxygen breathing. 
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